Back to Agenda
Session 11: Emerging Technologies Panel
Session Chair(s)
Jake Doran
Head of Digital
Lykos Therapeutics, United States
In this session, attendees will hear from a panel of experts that specialize in development and application of emerging technologies. As the usage of these technologies further matures, this panel of experts will bring forward well-defined use cases and success stories that have been used in practice within Regulatory. Topics to be discussed will include: Artificial Intelligence, Machine Learning, Robotic Process Automation, Unstructured Content usage, and the broader application of digital transformation across the Regulatory space.
Learning Objective : At the conclusion of this session, participants should be able to:
- Recognize the use case of robotic process automation and discuss the three potential needs for enabling success
- Identify at least 3 benefits drawn from analyzing unstructured content to aid in regulatory decision making
- Understand practical business cases for the usage of Artificial Intelligence
Speaker(s)
Panelist
Olaf Schoepke, PhD
Samarind, United Kingdom
Vice President, Regulatory Solutions
Panelists
Chrystal Zhang, MSc
Bayer Healthcare Co. Ltd., China
Senior Manager of Business Intelligence and Automation
Panelist
Thomas P Kivlehan
Docxonomy, United States
Chief Data Officer
Panelist
Daniel Chen, PhD
Veeva Systems, Canada
Senior Consultant
Panelist
Susant Mallick, MBA
Cloudhub BV, Netherlands
Founder and CEO, Life Sciences Practice Leader
Have an account?